| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
26,432.1710 | 18,925 | 4,879 | 40.3550 | 0 |
|
Cost of Revenue
|
-15,755.1100 | -10,341 | -2,239 | -134.9880 | -556.9250 |
|
Gross Profit
|
10,677.0610 | 8,584 | 2,640 | -94.6330 | 0 |
| Selling, General and Administrative Expenses
|
-11,711.2970 | -9,085 | -11,550 | -3,427.6900 | -4,279.1000 |
|
Research and Development Expenses
|
-5,531.0540 | -3,936 | -3,267 | -1,485.6360 | -2,386.0860 |
|
Operating Income/Expenses
|
-17,242.3510 | -13,021 | -14,817 | -4,913.3260 | -4,279.1000 |
|
Total Operating Profit/Loss
|
-6,565.2900 | -4,437 | -12,177 | -5,007.9590 | -4,279.1000 |
| Total Net Finance Income/Expense
|
-3,243.7110 | -2,639 | -4,498 | -544.8260 | 1,607.3000 |
| Net Investment Income
|
-161.2210 | -3,477 | 5,005 | 0 | -- |
| Irregular Income/Expenses
|
-10,424 | -1,770 | 3,230 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
-29.0450 | -8,761 | -561 | -544.5660 | 384.1080 |
|
Non-Operating Income/Expenses, Total
|
-13,857.9770 | -16,647 | 3,176 | -1,089.3920 | 1,991.4080 |
|
Pretax Income
|
-20,423.2670 | -21,084 | -9,001 | -6,097.3510 | -2,287.6920 |
|
Provision for Income Tax
|
1.7820 | 1 | 16 | -1.6000 | -486.6150 |
|
Net Income from Continuing Operations
|
-20,421.4850 | -21,083 | -8,985 | -6,098.9510 | -2,774.3070 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-20,421.4850 | -21,083 | -8,985 | -6,098.9510 | -2,774.3070 |
|
Net Income after Non-Controlling/Minority Interests
|
-20,421.4850 | -21,083 | -8,985 | -6,098.9510 | -2,774.3070 |
| Preferred/Other Stock Distribution
|
0 | 0 | -5,186 | 0 | -- |
|
Net Income Available to Common Stockholders
|
-20,421.4850 | -21,083 | -14,171 | -6,098.9510 | -2,774.3070 |
|
Diluted Net Income Available to Common Stockholders
|
-20,421.4850 | -21,083 | -14,171 | -6,098.9510 | -2,774.3070 |
| Basic EPS
|
-1.58 | -2.01 | -2.13 | -1.92 | -0.87 |
| Diluted EPS
|
-1.58 | -2.01 | -2.13 | -1.92 | -0.87 |
|
Basic Weighted Average Shares Outstanding
|
12,978.5000 | 10,476 | 6,659 | 3,180.0670 | 3,180.0670 |
|
Diluted Weighted Average Shares Outstanding
|
12,978.5000 | 10,476 | 6,659 | 3,180.0670 | 3,180.0670 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-17,179.5560 | -18,445 | -4,503 | -5,552.5250 | -3,894.9920 |
|
EBITDA
|
-17,083.5560 | -18,314 | -4,272 | -5,071.8310 | -3,894.9920 |
|
Normalized EBITDA
|
-4,968.3350 | -3,505 | -7,331 | -2,867 | -4,279.1000 |
|
Normalized Income
|
-8,307.3180 | -12,955.3820 | -16,532.5565 | -5,241.3238 | -3,077.7523 |
|
Total Unusual Items
|
12,115.2210 | 8,128 | -7,561 | 1,085.6040 | -384.1080 |
12/31/2022 - 11/4/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade